Gut check: could targeted vitamin B2 boost aging microbiomes?

NCT ID NCT07093463

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a colon-targeted form of vitamin B2 (riboflavin) can improve gut bacteria and digestive health better than regular vitamin B2 or a placebo. Researchers will enroll 90 healthy adults aged 50-70 to compare effects over 56 days. The goal is to understand how delivering vitamins directly to the gut may support a healthier microbiome.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROBIOME DYSBIOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • analyze & realize GmbH

    RECRUITING

    Berlin, State of Berlin, 10369, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••